< Back to previous page
Organisation
Digestive Oncology
Division
Main organisation:Department of Oncology
Lifecycle:1 Aug 2022 → Today
Organisation profile:
Digestive Oncology
Keywords:oncology
Disciplines:Oncology
Current researchers
1 - 10 of 12 results
- Sabine Tejpar (Responsible)
- Sarah Cappuyns (Member)
- Jeroen Dekervel (Member)
- Frederik Peeters (Member)
- Ting Pu (Member)
- Sabine Tejpar (Member)
- Baki Topal (Member)
- Eric Van Cutsem (Member)
- Fausto Velez Bravo (Member)
- Sara Verbandt (Member)
Projects
1 - 10 of 55
- Querying and exploiting the spatial colorectal tumor ecosystem for novel biological, diagnostic and therapeutic insightsFrom23 Nov 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- The evolutionary landscape of colorectal cancer, from polyp to metastasisFrom25 Oct 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Multicenter validation trial of [18F]AlF-FAPI-74 for PET imaging of cancer-associated fibroblasts through fibroblast activation protein inhibitors (FAPI) in digestive tumorsFrom1 Oct 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Optimizing a high throughput TCR-epitope recognition tool to characterize microbiome specific TCR interactions in colorectal cancerFrom1 Oct 2023 → TodayFunding: BOF - doctoral mandates
- Non-genetic drivers of YAP activation in colorectal cancerFrom26 Sep 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Study the efficacy and mechanism of targeted TIM3 and VISTA in the treatment of gastroesophageal junction / gastric cancer patients with low immunogenicity and FLOT chemotherapy resistanceFrom14 Feb 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Using mucins as friends in colorectal cancer diagnostics and treatmentFrom1 Jan 2023 → TodayFunding: Foundations, funds and other with scientific goal
- Infrastructure for Targeted ProteomicsFrom1 Jan 2023 → TodayFunding: BOF - scientific equipment program
- Unique IsoPlexis technology for multiplexed single cell functional profilingFrom1 Jan 2023 → TodayFunding: BOF - scientific equipment program
- Obesity-associated Hepatocellular Carcinoma at Single Cell Resolution for Risk Prediction and Novel Therapeutics - HepatoSCRIPTFrom1 Jan 2023 → TodayFunding: Foundations, funds and other with scientific goal
Publications
1 - 10 of 1024
- A PHASE III STUDY COMPARING LAROTAXEL TO 5-FU (CONTINUOUS INTRAVENOUS 5-FU OR CAPECITABINE) IN PATIENTS WITH ADVANCED PANCREATIC CANCER (APC) PREVIOUSLY TREATED WITH A GEMCITABINE CONTAINING REGIMEN(2010)
Authors: Eric Van Cutsem
Pages: 12 - 13 - Colon cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up(2008)
Authors: Eric Van Cutsem
Pages: 29 - 30 - Quantitative RT-PCR Detection of Colorectal Tumor Cells in Peripheral Blood-A Systematic Review(2008)
Authors: Gregory Sergeant, Freddy Penninckx, Baki Topal
Pages: 144 - 152 - Antioxidant response in the salema Sarpa Salpa: Interseasonal correlations with the diet(2011)
Authors: Jos van Pelt
Pages: 730 - 737 - ANTICOAGULANT MEDICATION EXPOSURE IN BEVACIZUMAB-TREATED PATIENTS: SUBGROUP ANALYSIS FROM THE BEVACIZUMAB EXPANDED ACCESS TRIAL (BEAT)(2010)
Authors: Eric Van Cutsem
Pages: 73 - 73 - Human epidermal growth factor receptor 2 (HER2) in gastric cancer (GC): results of the ToGA trial screening programme and recommendations for HER2 testing(2009)
Authors: Eric Van Cutsem
Pages: 364 - 364 - Induction of Epstein-Barr virus (EBV) lytic cycle in vitro causes oxidative stress in lymphoblastoid B cell lines(2009)
Authors: Jos van Pelt
Pages: 55 - 63 - Molecular markers and biological targeted therapies in metastatic colorectal cancer: expert opinion and recommendations derived from the 11th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2009(2010)
Authors: Eric Van Cutsem, Karin Haustermans
Pages: 1 - 10 - Assessment of the clinical benefit of combination therapy with cetuximab plus irinotecan in patients with mCRC who have progressed during prior treatment with irinotecan: An integrated analysis(2008)
Authors: Eric Van Cutsem
Pages: 77 - 78 - Effects of the EGFR Inhibitor Erlotinib on Magnesium Handling(2010)
Authors: Sabine Tejpar
Pages: 1309 - 1316